Modulation of the cardiovascular system by leptin

被引:19
作者
Abel, E. Dale [2 ,3 ]
Sweeney, Gary [1 ]
机构
[1] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada
[2] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Leptin; Cardiovascular; Metabolic syndrome; Heart failure; Obesity; HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; BLOOD-PRESSURE; MALONYL-COA; OBESITY; MECHANISMS; RESISTANCE; HYPERTENSION; METABOLISM; ACTIVATION;
D O I
10.1016/j.biochi.2012.03.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is well established that individuals with the metabolic syndrome have a significantly increased risk of cardiovascular disease and much effort has been expended to elicit the underlying mechanisms. Various studies have proposed that excessive or deficient physiological effects mediated by leptin make an important contribution, yet many paradoxical observations often preclude a clear definition of the role of leptin. This review article will briefly discuss principal and most recent evidence on direct and indirect regulation of the cardiovascular system by leptin, focusing on cardiac structural and functional as well as vascular effects. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:2097 / 2103
页数:7
相关论文
共 86 条
  • [21] Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease
    Glatz, Jan F. C.
    Luiken, Joost J. F. P.
    Bonen, Arend
    [J]. PHYSIOLOGICAL REVIEWS, 2010, 90 (01) : 367 - 417
  • [22] Grazette Luanda P, 2005, Heart Fail Clin, V1, P251, DOI 10.1016/j.hfc.2005.03.007
  • [23] Sensitivity of Cardiac Carnitine Palmitoyltransferase to Malonyl-CoA Is Regulated by Leptin: Similarities with a Model of Endogenous Hyperleptinemia
    Guzman-Ruiz, Rocio
    Somoza, Beatriz
    Gil-Ortega, Marta
    Merino, Beatriz
    Cano, Victoria
    Attane, Camille
    Castan-Laurell, Isabelle
    Valet, Philippe
    Fernandez-Alfonso, Maria S.
    Ruiz-Gayo, Mariano
    [J]. ENDOCRINOLOGY, 2010, 151 (03) : 1010 - 1018
  • [24] Ablation of the Leptin Receptor in the Hypothalamic Arcuate Nucleus Abrogates Leptin-Induced Sympathetic Activation
    Harlan, Shannon M.
    Morgan, Donald A.
    Agassandian, Khristofor
    Guo, Deng-Fu
    Cassell, Martin D.
    Sigmund, Curt D.
    Mark, Allyn L.
    Rahmouni, Kamal
    [J]. CIRCULATION RESEARCH, 2011, 108 (07) : 808 - U84
  • [25] Cardiovascular and Sympathetic Effects of Disrupting Tyrosine 985 of the Leptin Receptor
    Harlan, Shannon M.
    Morgan, Donald A.
    Dellsperger, David J.
    Myers, Martin G., Jr.
    Mark, Allyn L.
    Rahmouni, Kamal
    [J]. HYPERTENSION, 2011, 57 (03) : 627 - U478
  • [26] Leptin and cardiovascular diseases
    Hou, Ning
    Luo, Jian-Dong
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (12) : 905 - 913
  • [27] Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes
    Hou, Ning
    Luo, Miao-Shan
    Liu, Shi-Ming
    Zhang, Hai-Ning
    Xiao, Qing
    Sun, Pu
    Zhang, Gen-Shui
    Luo, Jian-Dong
    Chen, Min-Sheng
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1087 - 1095
  • [28] Attenuation of leptin and insulin signaling by SOCS proteins
    Howard, Jane K.
    Flier, Jeffrey S.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006, 17 (09) : 365 - 371
  • [29] Kalil G.Z., 2011, HYPERTENS RES
  • [30] Mechanisms of Cardiac Fibrosis in Inflammatory Heart Disease
    Kania, Gabriela
    Blyszczuk, Przemyslaw
    Eriksson, Urs
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2009, 19 (08) : 247 - 252